Education
About Us
Working with TipRanks
Follow Us
Revenio Group Corporation (GB:0KFH)
:0KFH
0KFH Stock Chart & Stats
Day’s Range― - ―
52-Week Range€22.40 - €35.74
Previous CloseN/A
Volume100.00
Average Volume (3M)1.55K
Market Cap
€676.04M
Enterprise Value€666.06M
Total Cash (Recent Filing)€22.20M
Total Debt (Recent Filing)€2.40M
Price to Earnings (P/E)35.8
Beta1.19
Next Earnings
Oct 30, 2025EPS EstimateN/A
Last Dividend Ex-Date
Apr 11, 2025Dividend Yield1.44%
Share Statistics
EPS (TTM)N/A
Shares Outstanding26,681,116
10 Day Avg. Volume2,621
30 Day Avg. Volume1,546
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€28.00Price Target Upside8.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Revenio News
0KFH FAQ
What was Revenio Group Corporation’s price range in the past 12 months?
Revenio Group Corporation lowest share price was €22.40 and its highest was €35.74 in the past 12 months.
What is Revenio Group Corporation’s market cap?
Revenio Group Corporation’s market cap is €676.04M.
When is Revenio Group Corporation’s upcoming earnings report date?
Revenio Group Corporation’s upcoming earnings report date is Oct 30, 2025 which is in 83 days.
How were Revenio Group Corporation’s earnings last quarter?
Currently, no data Available
Is Revenio Group Corporation overvalued?
According to Wall Street analysts Revenio Group Corporation’s price is currently Undervalued.
Does Revenio Group Corporation pay dividends?
Revenio Group Corporation pays a Annually dividend of €0.4 which represents an annual dividend yield of 1.44%. See more information on Revenio Group Corporation dividends here
What is Revenio Group Corporation’s EPS estimate?
Revenio Group Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Revenio Group Corporation have?
Revenio Group Corporation has 26,681,116 shares outstanding.
What happened to Revenio Group Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Revenio Group Corporation?
Currently, no hedge funds are holding shares in GB:0KFH
Company Description
Revenio Group Corporation
Revenio Group Oyj, a health technology company, designs, manufactures, and sells ophthalmic diagnostics and devices for the detection of glaucoma, macular degeneration, diabetic retinopathy, and cataracts in Finland, rest of Europe, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; DRSplus, a device for detection of diabetic retinopathy; iCare MAIA, a microperimeter to measure the visual field; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. It also provides Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.
Technical Analysis
Advanced Medical Solutions
―
Avacta Group plc
―
EKF Diagnostics Holdings
―
PureTech Health
―
Tristel
―
Venture Life
―
Ownership Overview
―
Insiders
3.32%
Mutual Funds
― Other Institutional Investors
93.38% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---